E-LIB Suche - Ergebnisse für: Wege, Henning

1

Impact of body mass index in patients receiving atezolizuma..:

Vithayathil, Mathew ; D'Alessio, Antonio ; Fulgenzi, Claudia Angela Maria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386929/. , 2023

Link: http://www.ncbi.nlm.nih...

2

EpCAM-positive circulating tumor cells and serum AFP levels..:

Kocheise, Lorenz ; Schoenlein, Martin ; Behrends, Berit...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682153/. , 2023

Link: http://www.ncbi.nlm.nih...

3

A meta-analysis and real-world cohort study on the sex-rela..:

Balcar, Lorenz ; Scheiner, Bernhard ; Fulgenzi, Claudia Angela Maria...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10809085/. , 2023

Link: http://www.ncbi.nlm.nih...

4

Cabozantinib in advanced hepatocellular carcinoma: efficacy..:

Finkelmeier, Fabian ; Scheiner, Bernhard ; Leyh, Catherine...
https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Cabozantinib_in_Advanced_Hepatocellular_Carcinoma_Efficacy_and_Safety_Data_from_an_International_Multicenter_Real-Life_Cohort/14709153. , 2022

Link: https://doi.org/10.18725..

5

Circulating tumor cells as a preoperative risk marker for o..:

Fründt, Thorben ; von Felden, Johann ; Krause, Jenny...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685781/. , 2022

Link: http://www.ncbi.nlm.nih...

6

Impact of older age in patients receiving atezolizumab and ..:

Vithayathil, Mathew ; D'Alessio, Antonio ; Fulgenzi, Claudia A. M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825835/. , 2022

Link: http://www.ncbi.nlm.nih...

7

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios ..:

Wu, Yue Linda ; Fulgenzi, Claudia Angela Maria ; D'Alessio, Antonio...
info:eu-repo/semantics/altIdentifier/pmid/36497316. , 2022

Link: https://hdl.handle.net/1..

8

Preliminary evidence of safety and tolerability of atezoliz..:

D'Alessio, Antonio ; Fulgenzi, Claudia Angela Maria ; Nishida, Naoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790703/. , 2022

Link: http://www.ncbi.nlm.nih...

9

Reproducible safety and efficacy of atezolizumab plus bevac..:

Fulgenzi, Claudia Angela Maria ; Cheon, Jaekyung ; D'Alessio, Antonio...
info:eu-repo/semantics/altIdentifier/pmid/36148739. , 2022

Link: https://hdl.handle.net/1..

10

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios ..:

Wu, Yue Linda ; Fulgenzi, Claudia Angela Maria ; D'Alessio, Antonio...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9737420/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Real-World Data for Lenvatinib in Hepatocellular Carcinoma ..:

Welland, Sabrina ; Leyh, Catherine ; Finkelmeier, Fabian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218621/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Prognosis of patients with hepatocellular carcinoma treated..:

Scheiner, Bernhard ; Pomej, Katharina ; Kirstein, Martha M...
https://boris.unibe.ch/160187/. , 2022

Link: https://boris.unibe.ch/1..

13

Assessing the impact of COVID-19 on liver cancer management..:

Muñoz-Martínez, Sergio ; Sapena, Victor ; Forner, Alejandro...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jhepr.2021.100260. , 2021

Link: https://hal.science/hal-..

14

Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy..:

Finkelmeier, Fabian ; Scheiner, Bernhard ; Leyh, Catherine...
https://boris.unibe.ch/160185/. , 2021

Link: https://boris.unibe.ch/1..

15

Assessing the impact of COVID-19 on liver cancer management..:

Muñoz-Martínez, Sergio ; Sapena, Victor ; Forner, Alejandro...
http://hdl.handle.net/10668/17255. , 2021

Link: http://hdl.handle.net/10..